The aquaporin4-IgG status and how it affects the clinical features and treatment response in NMOSD patients in Egypt
Abstract Background In Egypt, the characterization of Neuromyelitis Optica Spectrum Disorder (NMOSD) is lacking. Objectives To determine the demographics, clinical features, aquaporin4 antibodies (AQP4-IgG) status, and neuroimaging of Egyptian NMOSD patients. Methods Retrospective analysis of 70 NMO...
Main Authors: | Nirmeen A. Kishk, Walaa Abdelfattah, Nevin M. Shalaby, Hatem S. Shehata, Amr Hassan, Mohamed I. Hegazy, Noha T. Abokrysha, Doaa Abdellatif, Shereen M. Shawky, Sarah S. Abdo, Noha Taha, Amr M. Fouad, Alaa Elmazny, Amany H. Ragab |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-02-01
|
Series: | BMC Neurology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12883-021-02083-1 |
Similar Items
-
Neuromyelitis optica spectrum disorder (NMOSD) – diagnosis, epidemiology, clinical course, treatment
by: Agnieszka Damiza-Detmer, et al.
Published: (2019-05-01) -
Anti-aquaporin 4 IgG Is Not Associated With Any Clinical Disease Characteristics in Neuromyelitis Optica Spectrum Disorder
by: Oliver Schmetzer, et al.
Published: (2021-03-01) -
Adverse Events in NMOSD Therapy
by: Katrin Giglhuber, et al.
Published: (2022-04-01) -
AQP4-IgG NMOSD, MOGAD, and double-seronegative NMOSD: is it possible to depict the antibody subtype using magnetic resonance imaging?
by: Diego Cardoso Fragoso, et al.
Published: (2023-06-01) -
Neuromyelitis Optica Spectrum Disorders (NMOSD); Diagnostic criteria (ORP-56)
by: Maryam Poursadeghfard
Published: (2023-01-01)